Paula Hansen Sells 6,000 Shares of Docusign (NASDAQ:DOCU) Stock

Key Points

  • Insider James Shaughnessy sold 12,000 shares of DocuSign on Jan. 2 at an average price of $67.03 for $804,360, cutting his stake by 18.03% to 54,550 shares valued at roughly $3.66 million.
  • DocuSign stock opened at $65.19, trades in a one‑year range of $63.41–$99.30, has a market cap of $13.06 billion and a P/E of 45.59, and carries a consensus analyst rating of Hold with a $85.13 target.
  • Several firms recently trimmed price targets—Bank of America to $82 (neutral), Wedbush to $75 (neutral) and RBC to $70 (sector perform)—while a few others (BTIG, Wall Street Zen) have issued more positive views.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) CRO Paula Hansen sold 6,000 shares of the firm's stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $67.05, for a total value of $402,300.00. Following the completion of the sale, the executive directly owned 68,970 shares of the company's stock, valued at approximately $4,624,438.50. This trade represents a 8.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Docusign Stock Up 1.3%

NASDAQ:DOCU opened at $65.19 on Wednesday. The firm's fifty day simple moving average is $68.54 and its 200-day simple moving average is $73.02. The stock has a market cap of $13.06 billion, a PE ratio of 45.59, a price-to-earnings-growth ratio of 3.17 and a beta of 0.99. Docusign Inc. has a fifty-two week low of $63.41 and a fifty-two week high of $99.30.

Hedge Funds Weigh In On Docusign

A number of institutional investors have recently made changes to their positions in the stock. Palogic Value Management L.P. lifted its position in shares of Docusign by 2.2% in the first quarter. Palogic Value Management L.P. now owns 5,438 shares of the company's stock valued at $443,000 after acquiring an additional 117 shares in the last quarter. Centaurus Financial Inc. increased its position in Docusign by 2.6% during the 2nd quarter. Centaurus Financial Inc. now owns 5,398 shares of the company's stock worth $420,000 after purchasing an additional 136 shares in the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in Docusign by 31.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 595 shares of the company's stock valued at $46,000 after purchasing an additional 142 shares during the last quarter. Total Wealth Planning & Management Inc. lifted its holdings in Docusign by 4.8% in the 2nd quarter. Total Wealth Planning & Management Inc. now owns 3,170 shares of the company's stock valued at $247,000 after purchasing an additional 146 shares in the last quarter. Finally, Mitchell & Pahl Private Wealth LLC lifted its holdings in Docusign by 0.7% in the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 21,422 shares of the company's stock valued at $1,544,000 after purchasing an additional 149 shares in the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets




DOCU has been the subject of a number of research analyst reports. Bank of America dropped their target price on shares of Docusign from $102.00 to $82.00 and set a "neutral" rating for the company in a report on Friday, December 5th. Robert W. Baird lowered their price target on Docusign from $90.00 to $75.00 and set a "neutral" rating on the stock in a report on Friday, December 5th. UBS Group reduced their price objective on Docusign from $85.00 to $75.00 and set a "neutral" rating for the company in a report on Friday, December 5th. Weiss Ratings reissued a "hold (c)" rating on shares of Docusign in a report on Wednesday, October 8th. Finally, Wedbush dropped their price target on Docusign from $85.00 to $75.00 and set a "neutral" rating for the company in a research report on Friday, December 5th. Six research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to MarketBeat.com, Docusign presently has an average rating of "Hold" and a consensus price target of $85.13.

Check Out Our Latest Stock Analysis on Docusign

Docusign Company Profile

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Further Reading

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Docusign?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Docusign and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles